Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Lilly financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.
Stock Price
$903.6
2024-10-29
Market Capitalization
$903.4 B
2024-08-26
Revenue
$65.2 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|
| Revenue | 28.5B | 34.1B | 45.0B | 65.2B |
| Cost of goods sold | 6.6B | 7.1B | 8.4B | 11.1B |
| Gross profit | 21.9B | 27.0B | 36.6B | 54.1B |
| Gross profit margin, % | 76.8% | 79.2% | 81.3% | 83.0% |
| General and administrative expense | 6.4B | 7.4B | 8.6B | 11.1B |
| Operating expense total | 14.8B | 20.6B | 23.9B | 24.4B |
| Depreciation and amortization | 1.3B | |||
| Investment income | (410.7M) | (20.2M) | (49.5M) | |
| Interest income | 62.8M | 173.6M | 175.2M | |
| Interest expense | 331.6M | 485.9M | 780.6M | |
| Pre tax profit | 6.8B | 6.6B | 12.7B | 25.7B |
| Income tax expense | 561.6M | 1.3B | 2.1B | 5.1B |
| Net Income | 6.2B | 5.2B | 10.6B | 20.6B |
| EPS | 6.9 | 5.8 | 11.7 | 23.0 |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |